The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. by Ibrahim, Abdalla et al.
cancers
Article
The Effects of In-Plane Spatial Resolution on CT-Based
Radiomic Features’ Stability with and without ComBat
Harmonization
Abdalla Ibrahim 1,2,3,4,* , Turkey Refaee 1,5,† , Sergey Primakov 1,4,† , Bruno Barufaldi 6,
Raymond J. Acciavatti 6, Renée W. Y. Granzier 7 , Roland Hustinx 3, Felix M. Mottaghy 2,4,
Henry C. Woodruff 1,2 , Joachim E. Wildberger 2, Philippe Lambin 1,2 and Andrew D. A. Maidment 6


Citation: Ibrahim, A.; Refaee, T.;
Primakov, S.; Barufaldi, B.;
Acciavatti, R.J.; Granzier, R.W.Y.;
Hustinx, R.; Mottaghy, F.M.;
Woodruff, H.C.; Wildberger, J.E.; et al.
The Effects of In-Plane Spatial
Resolution on CT-Based Radiomic
Features’ Stability with and without







Received: 26 March 2021
Accepted: 8 April 2021
Published: 13 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 The D-Lab, Department of Precision Medicine, GROW—School for Oncology, Maastricht University,
6200 Maastricht, The Netherlands; t.refaee@maastrichtuniversity.nl (T.R.);
S.primakov@maastrichtuniversity.nl (S.P.); h.woodruff@maastrichtuniversity.nl (H.C.W.);
philippe.lambin@maastrichtuniversity.nl (P.L.)
2 Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+,
6200 Maastricht, The Netherlands; felix.mottaghy@mumc.nl (F.M.M.); j.wildberger@mumc.nl (J.E.W.)
3 Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics,
University Hospital of Liège and GIGA CRC-In Vivo Imaging, University of Liège, 4000 Liege, Belgium;
rhustinx@ulg.ac.be
4 Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA),
University Hospital RWTH Aachen University, 52074 Aachen, Germany
5 Department of Diagnostic Radiology, Faculty of Applied Medical Sciences, Jazan University,
Jazan 45142, Saudi Arabia
6 Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia,
PA 19104, USA; Bruno.Barufaldi@pennmedicine.upenn.edu (B.B.); racci@pennmedicine.upenn.edu (R.J.A.);
Andrew.Maidment@pennmedicine.upenn.edu (A.D.A.M.)
7 Department of Surgery, GROW—School for Oncology, Maastricht University Medical Centre+,
6200 Maastricht, The Netherlands; r.granzier@maastrichtuniversity.nl
* Correspondence: a.ibrahim@maastrichtuniversity.nl
† Authors contributed equally.
Simple Summary: Handcrafted radiomic features (HRFs) are quantitative features extracted from
medical images, and they are mined for associations with different clinical endpoints. While many
studies reported on the potential of HRFs to unravel clinical endpoints, the sensitivity of HRFs
to variations in scanning parameters is affecting the inclusion of radiomic signatures in clinical
decision-making. In this study, we investigated the effects of variations in the in-plane resolution
of scans, while all other scanning parameters were fixed. Moreover, we investigated the effects
of ten different image resampling methods and ComBat harmonization on the reproducibility of
HRFs. Our results show that the majority of HRFs are significantly and variably affected by the
differences in in-plane resolution. The majority of image resampling methods resulted in a higher
number of reproducible HRFs compared to ComBat harmonization. Our developed framework
guides identifying the reproducible and harmonizable HRFs in different scenarios.
Abstract: While handcrafted radiomic features (HRFs) have shown promise in the field of personal-
ized medicine, many hurdles hinder its incorporation into clinical practice, including but not limited
to their sensitivity to differences in acquisition and reconstruction parameters. In this study, we evalu-
ated the effects of differences in in-plane spatial resolution (IPR) on HRFs, using a phantom dataset (n
= 14) acquired on two scanner models. Furthermore, we assessed the effects of interpolation methods
(IMs), the choice of a new unified in-plane resolution (NUIR), and ComBat harmonization on the
reproducibility of HRFs. The reproducibility of HRFs was significantly affected by variations in
IPR, with pairwise concordant HRFs, as measured by the concordance correlation coefficient (CCC),
ranging from 42% to 95%. The number of concordant HRFs (CCC > 0.9) after resampling varied
depending on (i) the scanner model, (ii) the IM, and (iii) the NUIR. The number of concordant HRFs
after ComBat harmonization depended on the variations between the batches harmonized. The
majority of IMs resulted in a higher number of concordant HRFs compared to ComBat harmonization,
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and the combination of IMs and ComBat harmonization did not yield a significant benefit. Our
developed framework can be used to assess the reproducibility and harmonizability of RFs.
Keywords: image processing; harmonization; reproducibility; radiomics biomarkers
1. Introduction
In recent years, quantitative medical imaging research using handcrafted radiomic fea-
tures (HRFs) has been growing exponentially [1,2]. Radiomics refers to the high throughput
extraction of quantitative imaging features that are expected to correlate with clinical and
biological characteristics of patients [3,4]. For decades, it has been hypothesized that image
texture analysis could potentially extract more information from a region of interest (ROI)
than that solely perceived by the human eye [5,6]. Yet, the term radiomics has only been
introduced recently [7,8]. HRFs are generally grouped into shape, intensity, and textural
features. To date, many studies have reported on the potential of radiomics to predict
various clinical endpoints [9,10]. However, major challenges, including the reproducibility
of the HRFs across different acquisition and reconstruction parameters, have hindered the
incorporation of radiomics in clinical decision support systems [11,12].
The essence of radiomics is that certain HRFs help decode biologic information [8],
allowing these features to be treated as biomarkers. The mainstay of a biomarker is the
ability to quantify it in a reproducible manner [13]. HRFs are mathematical equations
applied to numeric arrays of intensity values that form the medical image. Therefore, it
is intuitive that changes in the values in the array (due to differences in scan acquisition
and reconstruction parameters), by the transitive property, lead to (potentially significant)
quantitative changes in the HRFs. It is well established that changes in scan acquisition
and reconstruction parameters affect the values in the array representing the medical
image [14]. Therefore, it is a common clinical practice to scan a phantom to calibrate the CT
scanner on a routine basis. Hence, similar practices are needed before radiomics studies are
conducted, when the scans under analysis were acquired using heterogeneous acquisition
and reconstruction parameters [15]. Many studies have already reported on the sensitivity
of HRFs to different factors, including (i) temporal variability, or test–retest [16,17], in
which two scans of a patient (or a phantom) are taken after a time interval using the
exact scanning parameters; and (ii) scanning parameters variability [11,18,19], in which an
object (usually a phantom) is scanned multiple times using different scanning parameters.
Variations in the majority of scanner/scanning parameter combinations were reported to
impact the reproducibility of HRFs significantly [18–20].
One scan reconstruction parameter expected to have an effect on the reproducibility
of HRFs is the in-plane spatial resolution (IPR), which is dictated in part by the pixel
dimensions, while the through-plane spatial resolution is determined by the slice thickness
and slice spacing. Resampling all the scans in a dataset to a new unified in-plane spatial
resolution (NUIR) before feature extraction has been employed as a method to reduce the
variation in radiomic feature values [21,22]. The NUIR is usually decided based on the
most frequent IPR in the dataset, and different interpolation methods (IMs) can be used
for this purpose. Interpolation is a model-based method to recover continuous data from
discrete data within a known range of data spacings (i.e., pixel size in images) [23]. The
degree to which data recovery is possible is highly sensitive to the interpolation method
and the underlying data structure. In the case of medical imaging analysis, interpolation is
employed either to convert the spatial sampling rate (measured in pixels or voxel count
per unit of length per dimension) to another or to distort the image in the case of image
registration [24]. Since the vast majority of HRFs are derived from pixel/voxel values
and their distributions, interpolation to a common pixel spacing could potentially reduce
variance introduced to these HRFs arising from differences in IPR.
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As a rule, one must distinguish between interpolation methods that increase or reduce
the image resolution. Interpolation from smaller pixels to larger pixels (i.e., reducing spatial
resolution) usually involves some form of averaging, with the possible exception of modern
deep learning-based methods.
Generally, while data acquired with small pixels will contain more noise, the process
of averaging to large pixels will ameliorate the noise properties. As such, the process is
less sensitive to the interpolation method/model. On the other hand, interpolation from
larger pixels to smaller pixels (i.e., increasing spatial resolution) is fraught with challenges,
as the interpolated data can be highly sensitive to the interpolation model due to the need
to create de novo pixel values. Larger pixels average the signal over a larger area than
smaller ones, leading to the loss of variations in the original scene that occur over spatial
frequencies smaller than the Nyquist limit and cannot be recovered exactly.
Certain methods, such as nearest neighbor interpolation (also called pixel replication),
while fast, are less accurate than other methods such as sinc interpolation or deep-learning
methods (which are trained with representative data). However, all such interpolation
methods are sensitive to biases arising from the image [25]. The application of these
methods to medical imaging has been evaluated qualitatively [26]. Yet, the effects of these
methods on the reproducibility of HRFs is not well understood. Unlike humans, whose
exposure to a vast assortment of scanners, patients, and acquisition conditions (including
IPR) leads to a tolerance for such changes, IPR is likely to have more profound effects on
HRFs.
A harmonization method that has become increasingly common in the field of ra-
diomics is ComBat. ComBat was originally developed for the harmonization of gene
expression arrays [27]. Several studies have investigated the potential of ComBat in ra-
diomics analysis and recommended its use [28,29]. We hypothesize that ComBat, the
chosen IM, and the selected NUIR will affect the reproducibility of HRFs differently. In
this study, the reproducibility of HRFs was assessed across different IPRs, while keeping
all other parameters fixed, using a public dataset of CT scans of a phantom. A thorough
investigation of the applicability of 10 different IMs was performed in an effort to identify
suitable IMs for the purpose of increasing the number of reproducible HRFs in a hetero-
geneous dataset. In particular, we investigated whether data with discordant pixel sizes
need to be interpolated to a common pixel size to perform radiomics analysis, and we also
investigated how the choice of IM and NUIR, as well as ComBat harmonization, affects
the reproducibility of HRFs. Furthermore, we developed a generalizable workflow that
assesses the impact of different harmonization techniques (Figure 1) on the reproducibility
of RFs. Ultimately, the goal of our work is to guide robust radiomics analysis to ease its
incorporation in clinical decision-making.Cancers 2021, 13, x 4 of 17  
 
 
Figure 1. Proposed reproducible radiomic analysis workflow. 
2. Materials and Methods 
2.1. Phantom Data 
The publicly available Credence Cartridge Radiomics (CCR) phantom data [30] 
found in The Cancer Imaging Archive (TCIA.org) [31] was used. The CCR phantom is 
composed of 10 different layers that correspond to different texture patterns spanning a 
range of almost −900 to +700 HU (Figure S1). The publicly available dataset includes 251 
scans of the phantom acquired using six scanner models manufactured by three different 
manufacturers. The scans were acquired using various acquisition and reconstruction pa-
rameters to assess the reproducibility of HRFs. For the purpose of this study, 14 scans 
acquired using 2 different scanner models (Discovery STE & LightSpeed Pro 32) of the 
same manufacturer (GE), which were all acquired at a single slice thickness (1.25 mm), 
tube voltage (120 kV), tube current (250 mA), and convolution kernel (standard), but var-
ying IPR (Table 1) were used. The reasoning behind this selection is multifold: (i) the ef-
fects of the variations are expected to be dependent on the heterogeneity in acquisition; 
(ii) the number and complexity of the different combinations available are too huge to be 
described, analyzed, and presented in a single experiment; (iii) the data under analysis 
were acquired using the same scanner models, and the same acquisition and reconstruc-
tion parameters except for the in-plane resolution, which allows the assessment of the 
effect of variations in this single parameter. 
Table 1. Scanning parameters of the phantom data. 
Scanner Pixel Spacing (mm2) 
Discovery STE LightSpeed Pro 32  
CCR-2-001 CCR-2-022 0.39 × 0.39 
CCR-2-002 CCR-2-023 0.49 × 0.49 
CCR-2-003 CCR-2-024 0.59 × 0.59 
CCR-2-004 CCR-2-025 0.68 × 0.68 
CCR-2-005 CCR-2-026 0.78 × 0.78 
CCR-2-006 CCR-2-027 0.88 × 0.88 
CCR-2-007 CCR-2-028 0.98 × 0.98 
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2. Materials and Methods
2.1. Phantom Data
The publicly available Credence Cartridge Radiomics (CCR) phantom data [30] found
in The Cancer Imaging Archive (TCIA.org) [31] was used. The CCR phantom is composed
of 10 different layers that correspond to different texture patterns spanning a range of
almost −900 to +700 HU (Figure S1). The publicly available dataset includes 251 scans of the
phantom acquired using six scanner models manufactured by three different manufacturers.
The scans were acquired using various acquisition and reconstruction parameters to assess
the reproducibility of HRFs. For the purpose of this study, 14 scans acquired using 2
different scanner models (Discovery STE & LightSpeed Pro 32) of the same manufacturer
(GE), which were all acquired at a single slice thickness (1.25 mm), tube voltage (120 kV),
tube current (250 mA), and convolution kernel (standard), but varying IPR (Table 1) were
used. The reasoning behind this selection is multifold: (i) the effects of the variations
are expected to be dependent on the heterogeneity in acquisition; (ii) the number and
complexity of the different combinations available are too huge to be described, analyzed,
and presented in a single experiment; (iii) the data under analysis were acquired using
the same scanner models, and the same acquisition and reconstruction parameters except
for the in-plane resolution, which allows the assessment of the effect of variations in this
single parameter.
Table 1. Scanning parameters of the phantom data.
Scanner Pixel Spacing (mm2)
Discovery STE LightSpeed Pro 32
CCR-2-001 CCR-2-022 0.39 × 0.39
CCR-2-002 CCR-2-023 0.49 × 0.49
CCR-2-003 CCR-2-024 0.59 × 0.59
CCR-2-004 CCR-2-025 0.68 × 0.68
CCR-2-005 CCR-2-026 0.78 × 0.78
CCR-2-006 CCR-2-027 0.88 × 0.88
CCR-2-007 CCR-2-028 0.98 × 0.98
2.2. Interpolation and Image Resampling
The effects of the IMs included in the popular open-source radiomics toolbox PyRa-
diomics [32] were assessed in this study. The methods are based on the python library
Simple-ITK [33], and they include (i) nearest neighbor (NN), (ii) linear, (iii) basis spline
(B-spline), (iv) Gaussian, (v) Gaussian using labelling (mask) information (LabelGaussian),
and windowed sinc interpolations using the following window types: (vi) Hamming
(HammingWindowedSinc or HWS), (vii) Cosine (CosineWindowedSinc or CWS), (viii)
Welch (WelchWindowedSinc or WWS), (ix) Lanczos (LanczosWindowedSinc or LWS), and
(x) Blackman (BlackmanWindowedSinc or BWS).
The simplest of these IMs, and the ones with the lowest computational costs, are (i) the
NN interpolation, which functions by assigning any new voxel the same value as its closest
neighbor in the original image; and (ii) linear interpolation, in which the values of new
pixels are interpolated linearly between the two original values [26]. B-spline interpolation
is more complex than NN or linear; the calculations span four pixels [34]. While the method
performs well in terms of radiologic evaluation in which the aim is to convince human
observers, it is known to unnecessarily over-smooth the image [26]. The windowed sinc
functions are complex convolution-based interpolations that are based on multiplying
the sinc function by a limited spatial support window to reduce unwanted effects on the
resampled image [35], which is followed by filtering of the frequencies to avoid the injection
of spurious frequency components. Windowed sinc functions are generally considered
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superior to other interpolation methods, as little superfluous noise is injected into the
interpolated images.
2.3. HRFs Extraction
Each scan contained 10 independent regions of interest (ROIs) (one for each layer of
the phantom) that occupy the same physical area of the phantom on each scan. For each
ROI, HRFs were calculated using the open source software Pyradiomics V 2.1.2. HRFs
were extracted multiple times to perform different experiments. First, to assess the effect of
differences in in-plane resolution and ComBat harmonization on HRFs, no changes to the
original in-plane resolution were made. Second, to assess the effect of different IMs and
NUIRs and the combination of interpolation and ComBat, HRFs were extracted from the
scans using all IMs and all available NUIRs in the dataset (Table 1).
For each set of scans (7 scans, with 10 ROIs per scan) from each scanner model (n = 2),
HRFs were extracted 71 times. The HRFs were extracted one time from the original scans
and 70 times with unique combinations of IM and NUIR. In each run, a total of 91 original
RFs were extracted. In Pyradiomics, shape features are calculated on the original input
image, and they are not affected by the in-application resampling. Therefore, those HRFs
were excluded.
To reduce noise and computational requirements, images were pre-processed by bin-
ning voxel grayscale values into bins with a fixed width of 25 Hounsfield units (HUs)
for extracting HRFs from unfiltered images. No other image pre-processing steps were
performed. The extracted HRFs included HU intensity features, and texture features de-
scribing the spatial distribution of voxel intensities using 5 texture matrices (gray-level
co-occurrence (GLCM), gray-level run-length (GLRLM), gray-level size-zone (GLSZM),
gray-level dependence (GLDM), and neighborhood gray-tone difference (NGTDM) ma-
trices). A more detailed description of the Pyradiomics HRFs can be found online (https:
//pyradiomics.readthedocs.io/en/latest/features.html (accessed on 7 January 2021)).
2.4. ComBat Harmonization
ComBat is an empirical Bayes based method used to estimate the effects of different
batches on HRFs; in this scenario, variations in scan acquisition and reconstruction pa-
rameters were considered [27]. The ComBat method assumes that a feature value can be
approximated by the equation:
Yij = α + βXij + γi + δiεij (1)
where α is the average value for feature Yij for ROI j on scanner i; X is a design matrix of
the biologic covariates known to affect the HRFs; β is the vector of regression coefficients
corresponding to each biologic covariate; γi is the additive effect of scanner i on HRFs, δi
is the multiplicative scanner effect, and εij is an error term, which is presupposed to be
normally distributed with zero mean. Based on the values estimated, ComBat performs
feature transformation in the form of:
YComBatij =
(
Yij − α̂ − β̂Xij − γ∗i
)
δ∗i
+ â + β̂Xij (2)
where α̂ and β̂ are estimators of parameters α and β, respectively. γ∗i and δ
∗
i are the
empirical Bayes estimates of γi and δi, respectively [28].
2.5. Statistical Analysis
To assess the agreement of a given HRF for the same ROI scanned using different
settings and scanners, the concordance correlation coefficient (CCC) was calculated using
the epiR package (Version 0.9–99) [36] and R language (Version 3.5.1) [37] with R studio
(Version 1.1.456) [38]. The CCC is used to evaluate the agreement between paired read-
ings [38], and it provides the measure of concordance as a value between 1 and −1, where
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0 represents no concordance and 1 or −1 represent a perfect direct positive or inverse
concordance, respectively. The CCC metric further has the advantages of (i) robustness in
small sample sizes and (ii) taking the rank and value of the feature into consideration [39].
The cut-off of (CCC > 0.9) was used to select reproducible HRFs, as the literature suggests
that values < 0.9 indicate poor concordance [40].
Four different approaches for assessing concordances of HRFs were used (Figure 2):
(i) HRFs extracted from the original scans; (ii) HRFs extracted from the original scans
and harmonized using ComBat; (iii) HRFs extracted from resampled scans; and (iv) HRFs
extracted from resampled scans harmonized using ComBat. For (i), the CCC was calculated
for all HRFs of all ROIs across 7 different scans from each scanner. In each run, the CCC
was calculated between a different pair of scans. For (ii), HRFs with nearly zero variance
(i.e., HRFs which have the same value in 95% or more of the data points) had to be removed
before applying ComBat. Parametric prior estimations were used, and no reference batch
was assigned for ComBat application. CCC was calculated after harmonizing the remaining
HRFs using ComBat. In each run, ComBat was applied on two batches (scans). For (iii), the
CCC was calculated for the HRFs following feature extraction with each of the IMs. The
effects of the NUIR were assessed by calculating the CCC for the HRFs after resampling all
the scans to one of the available in-plane resolutions. For (iv), ComBat was applied after the
same process in (iii), and then, the CCC was calculated. To gauge an overall image of the
reproducibility of HRFs across all pairs as well as the impact of IMs, NUIRs, and ComBat,
the number (percentage) of HRFs that were reproducible by taking the intersection of HRFs
that were reproducible in each pairwise comparison of a certain scenario were compared
(21 pairs in each scenario as shown in Tables 2–5).




Figure 2. Reproducibility analysis approaches. 
Furthermore, we assessed the correlation between the HRFs that were concordant 
across all pairwise comparisons on each scanner model, using Spearman correlation [41]. 
HRFs were considered highly correlated if the Spearman’s correlation coefficient had a 
value > 0.90. 
3. Results 
3.1. Approach (i): Effects of IPR on the Reproducibility of HRFs 
The number of HRFs insensitive to the variations in IPR depended on the scanner 
model (Tables 2 and S1). In pairwise comparisons, the number of concordant HRFs was 
lower when the difference in IPR between the scan pairs was greater. The lowest concord-
ance was observed between the scan with the highest resolution and the scan with the 
lowest resolution. 
Out of the 91 extracted HRFs, between 39 (42.9%) and 86 (94.5%) HRFs were concord-
ant, varying pairwise and scanner wise. Some HRFs were robust to variations in IPR in 
one scanner model and not in the other. 
Table 2. Number of pairwise concordant handcrafted radiomic features (HRFs) with a concord-
ance correlation coefficient (CCC) > 0.9 before resampling, Discovery STE model. 
Scan CCR-2-001 CCR-2-002 CCR-2-003 CCR-2-004 CCR-2-005 CCR-2-006 
CCR-2-002 75 (82.4%)      
CCR-2-003 57 (62.6%) 78 (85.7%)     
CCR-2-004 53 (58.2%) 64 (70.3%) 83 (91.2%)    
CCR-2-005 50 (54.9%) 61 (67.0%) 72 (79.1%) 86 (94.5%)   
CCR-2-006 51 (56.0%) 58 (63.7%) 68 (74.7%) 76 (83.5%) 85 (93.4%)  
CCR-2-007 39 (42.9%) 42 (46.2%) 44 (48.4%) 52 (57.1%) 60 (64.9%) 83 (91.2%) 
On the Discovery STE model (GE), the number of concordant HRFs ranged between 
39 (42.9%) and 86 (94.5%), with a median of 70 (39.6%) HRFs (Table 2). A total of 36 (39.6%) 
Figure 2. Reproducibility analysis approaches.
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Table 2. Number of pairwise concordant handcrafted radiomic features (HRFs) with a concordance
correlation coefficient (CCC) > 0.9 before resampling, Discovery STE model.
Scan CCR-2-001 CCR-2-002 CCR-2-003 CCR-2-004 CCR-2-005 CCR-2-006
CCR-2-002 75 (82.4%)
CCR-2-003 57 (62.6%) 78 (85.7%)
CCR-2-004 53 (58.2%) 64 (70.3%) 83 (91.2%)
CCR-2-005 50 (54.9%) 61 (67.0%) 72 (79.1%) 86 (94.5%)
CCR-2-006 51 (56.0%) 58 (63.7%) 68 (74.7%) 76 (83.5%) 85 (93.4%)
CCR-2-007 39 (42.9%) 42 (46.2%) 44 (48.4%) 52 (57.1%) 60 (64.9%) 83 (91.2%)
Table 3. Number of pairwise concordant HRFs with a CCC > 0.9 after ComBat harmonization,
Discovery STE model.
Scan CCR-2-001 CCR-2-002 CCR-2-003 CCR-2-004 CCR-2-005 CCR-2-006
CCR-2-002 79 (86.8%)
CCR-2-003 65 (71.4%) 79 (86.8%)
CCR-2-004 59 (64.8%) 70 (76.9%) 83 (91.2%)
CCR-2-005 58 (63.7%) 66 (72.5%) 75 (82.4%) 87 (95.6%)
CCR-2-006 57 (62.6%) 65 (71.4%) 70 (76.9%) 84 (92.3%) 86 (94.5%)
CCR-2-007 48 (52.7%) 55 (60.4%) 57 (62.6%) 60 (65.9%) 73 (80.2%) 84 (92.3%)
Table 4. Number of pairwise concordant HRFs with a CCC > 0.9 after resampling * using CosineWin-
dowedSinc (CWS), Discovery model.
Scan CCR-2-001 CCR-2-002 CCR-2-003 CCR-2-004 CCR-2-005 CCR-2-006
CCR-2-002 89 (97.8%)
CCR-2-003 86 (94.5%) 88 (96.7%)
CCR-2-004 86 (94.5%) 85 (93.4%) 88 (96.7%)
CCR-2-005 86 (94.5%) 88 (96.7%) 91 (100%) 89 (97.8%)
CCR-2-006 78 (85.7%) 77 (84.6%) 83 (91.2%) 79 (86.8%) 88 (96.7%)
CCR-2-007 53 (58.2%) 53 (58.2%) 55 (60.4%) 54 (59.3%) 60 (65.9%) 85 (93.4%)
* All scans were resampled to the median pixel spacing value (0.49 × 0.49 mm2).
Table 5. Number of pairwise concordant HRFs with a CCC > 0.9 after ComBat following resampling
* using CWS, Discovery STE model.
Scan CCR-2-022 CCR-2-023 CCR-2-024 CCR-2-025 CCR-2-026 CCR-2-027
CCR-2-023 89 (97.8%)
CCR-2-024 86 (94.5%) 88 (96.7%)
CCR-2-025 86 (94.5%) 85 (93.4%) 88 (96.7%)
CCR-2-026 86 (94.5%) 88 (96.7%) 91 (100%) 89 (97.8%)
CCR-2-027 79 (86.8%) 78 (85.7%) 84 (92.3%) 84 (92.3%) 89 (97.8%)
CCR-2-028 57 (62.6%) 61 (67.0%) 60 (65.9%) 59 (64.8%) 72 (79.1%) 85 (93.4%)
* All scans were resampled to the median pixel spacing value (0.49 × 0.49 mm2).
Furthermore, we assessed the correlation between the HRFs that were concordant
across all pairwise comparisons on each scanner model, using Spearman correlation [41].
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HRFs were considered highly correlated if the Spearman’s correlation coefficient had a
value > 0.90.
3. Results
3.1. Approach (i): Effects of IPR on the Reproducibility of HRFs
The number of HRFs insensitive to the variations in IPR depended on the scanner
model (Table 2 and Table S1). In pairwise comparisons, the number of concordant HRFs
was lower when the difference in IPR between the scan pairs was greater. The lowest
concordance was observed between the scan with the highest resolution and the scan with
the lowest resolution.
Out of the 91 extracted HRFs, between 39 (42.9%) and 86 (94.5%) HRFs were concor-
dant, varying pairwise and scanner wise. Some HRFs were robust to variations in IPR in
one scanner model and not in the other.
On the Discovery STE model (GE), the number of concordant HRFs ranged between
39 (42.9%) and 86 (94.5%), with a median of 70 (39.6%) HRFs (Table 2). A total of 36 (39.6%)
HRFs were reproducible regardless of the IPR selected when all other scanning parameters
were fixed (List S1). Of these 36 HRFs, nine remained after removing highly correlated
HRFs (List S3), and none was highly correlated with volume. Overall, the Lightspeed
Pro 32 model showed lower concordance than the Discovery STE model. The number of
pairwise concordant HRFs on the Lightspeed Pro 32 model ranged between 39 (42.8%)
and 82 (90.1%), with a median of 60 (65.9%) (Table S1). A total of 27 (29.7%) HRFs were
reproducible across all pairs (List S2). Of these 27 HRFs, nine remained after removing
highly correlated HRFs (List S4), and none was highly correlated with volume. Twenty-six
(28.6%) HRFs were reproducible on both scanner models regardless of the IPR.
3.2. Approach (ii): ComBat Harmonization of HRFs Extracted from Original Scans
ComBat harmonization increased the number of concordant HRFs compared to before
harmonization. On the Discovery model, the increment in the number (percentage) of HRFs
ranged between 0 (0%) and 13 (14.3%), with a median of 6 (6.6%) of the total depending on
the batches being harmonized (Table 3). 46 (50.5%) HRFs were found to be reproducible
across all pairwise comparisons following ComBat harmonization, 35 of which were found
to be highly correlated. The number of concordant HRFs decreased with the increment in
IPR variation. Hence, the increment in the number of concordant HRFs was larger when
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On the Discovery STE model, the use of windowed sinc IMs resulted in an overall
increment in the number of reproducible HRFs, regardless of the NUIR selected. The range
of HRFs that had an improved concordance across all pairs when using windowing sinc
was between 14 (15.4%) and 20 (22%) HRFs, depending on the NUIR. When scans were
resampled to the highest resolution using CWS, the increment in the number of concordant
HRFs ranged between −2 (−2.2%) and 36 (39.6%), with a median of 12 (13.2%) HRFs.
Moreover, 47 (51.6%) HRFs were concordant across all pairs. When scans were resampled
to the lowest resolution using CWS, the increment in the number of concordant HRFs
ranged between 4 (4.4%) and 35 (38.5%), with a median of 16 (17.6%) HRFs. 54 (59.3%)
HRFs were concordant across all pairs. Table 4 shows the pairwise number (percentage) of
reproducible HRFs following resampling to the median IPR value with CWS IM on the
Discovery model for comparison with Table 5.
HWS performed the best when he images were resampled to a NUIR equal to or lower
than the median (0.49 × 0.49 mm2), while CWS, WWS, and LWS methods performed better
on NUIR values higher than the median. BSpline IM resulted in a minor to significant
increment in the number of reproducible HRFs, with a higher number of concordant
features when higher NUIRs where chosen. Gaussian and Label-Gaussian IMs consistently
resulted in lower numbers of concordant HRFs. The number of HRFs losing concordance
across all pairs when using a Gaussian IM ranged between −29 (−31.9%) and −30 (−33%)
HRFs, while the range for LabelGaussian was between −11 (−12.1%) and −19 (−20.9%)
HRFs, depending on the NUIR. The rest of IMs (NN and Linear) resulted in an overall
decrease in th nu ber of concord t HRFs when an NUIR below the median resolution
was selected, and there was a minor-significant improvement with NUIRs higher than the
median resolution (Table S5).
On the Lightspeed Pro 32 model, windowed sinc IMs (except for BWS) showed a
consistent increment in the number of reproducible HRFs, which was varying depending on
the NUIR. When scans were resampled to the highest resolution using CWS, the increment
in the number of concordant HRFs ranged between −9 (−9.9%) and 36 (39.6%), with a
median of 8 (8.8%) HRFs. Thirty (33%) HRFs were concordant across all pairs. When
scans were resampled to the lowest resolution using CWS, the increment in the number
of concordant HRFs ranged between −3 (−3.3%) and 31 (34.1%), with a median of 16
(17.6%) HRFs. 38 (41.8 %) HRFs were concordant across all pairs. Table S3 shows the
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pairwise number (percentage) of concordant HRFs following resampling to the median
IPR value with CWS IM on the LightSpeed Pro 32 model, for comparison with Table S4.
The application of other IMs (BWS, NN, Linear, Gaussian, and Label-Gaussian) with an
NUIR other than the two lowest resolutions available resulted in an overall decrease in the
number of concordant HRFs. However, when the lowest resolution was selected as NUIR,
BSpline IM outperformed all other methods when the number of concordant HRFs across
all pairs was considered (Table S6).
3.4. Approach (iv): The Combination of IMs and ComBat Harmonization
Approach (iii) resulted in a higher number of concordant HRFs in the majority of
pairwise scenarios compared to approach (ii) for the majority of IMs that performed solely
well (for example, Table 3 vs. Table 4). The application of ComBat harmonization on
HRFs extracted from resampled scans varied per scanner model, IMs, NUIRs, and batches.
However, when the number of concordant HRFs across all pairs is considered, ComBat
increased the number of concordant HRFs in almost all of the investigated scenarios
(Figure 4 and Figure S3; Tables S7 and S8).
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On the Discovery model, the increment in the number (percentage) of concordant
HRFs extracted from scans resampled to the highest resolution after ComBat harmonization
ranged between 0 (0%) and 10 (11%), with a median increment of 0 (0%) of the total number
of HRFs compared to before harmonization. Fifty-four (59.3%) HRFs were concordant
across all pairs. When ComBat was applied on HRFs extracted from scans resampled to
the lowest resolution, the increment in the number (percentage) of HRFs ranged between
−1 (−1.1%) and 10 (11%) HRFs, with a median of 0 (0%), depending on the batches being
harmonized. Sixty-one (67%) were found to be stable across all pairs. Table 5 shows
the number of pairwise concordant HRFs following the application of ComBat on scans
acquired on the Discovery STE model and resampled to the median IPR value using
CWS IM.
On the LightSpeed Pro 32 model, the increment in the number (percentage) of concor-
dant HRFs after ComBat harmonization on HRFs extracted from scans resampled to the
highest resolution (lowest concordance) ranged between −1 (−1.1%) and 13 (14.3%) HRFs,
with a median of 3 (3.3%) of the total number of HRFs compared to before harmonization.
Forty-two (46.2%) HRFs were concordant across all pairs. When ComBat was applied on
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HRFs extracted from scans resampled to the lowest resolution (highest concordance), the
increment in the number (percentage) of HRFs ranged between 0 (0%) and 10 (11%) HRFs,
with a median increment of 1 (1.1%) feature. Fifty-one (56%) HRFs were concordant across
all pairs. Table S4 shows the pairwise CCC following the application of ComBat on scans
acquired with the LightSpeed Pro 32 model and resampled to the median IPR value using
CWS IM.
4. Discussion
In this study, the effects of variations in scans’ IPR on the reproducibility of HRFs,
the proper methodology of identifying HRFs that are reproducible across different IPRs,
and how to properly adjust for these differences before performing radiomics analysis
using image interpolation and/or ComBat harmonization were thoroughly investigated.
Uniquely, this study evaluates the effects of all the different IMs and the choice of NUIRs
on the reproducibility of HRFs. Previous studies usually investigated a single IM with a
single NUIR [21,22].
While two batches of scans acquired with the same imaging parameters on two scanner
models of the same vendor were used for analysis, the effects of IPR, ComBat, IMs, and
NUIR on the reproducibility of HRFs varied on each of the scanner models. The CCC
was calculated pairwise to assess the reproducibility of HRFs when different sets of data
were used as batches. Calculating the pairwise CCC between HRF values extracted before
resampling the images revealed that the reproducibility of HRFs in our data depended
on several factors including, but not limited to, the definition of the HRF, the degree of
variation in IPR, and the scanner (hardware) make/model. Addressing the effects of these
factors is crucial for performing robust radiomics analysis.
Without performing image preprocessing, the number of reproducible HRFs varied
according to the batches being assessed. The aim of this study was to show that different in-
vestigated scenarios showed different numbers of reproducible HRFs. Therefore, although
36 HRFs for the Discovery STE scanner (27 HRFs for LightSpeed Pro 32 scanner) were
always included in the set of concordant HRFs, it is difficult to conclude that these HRFs
are insensitive to spatial resolution on all other scanner models based on our experiments.
Yet, our framework guides the methodology of identifying reproducible HRFs according
to the data under analysis. As we have shown, the number and type of HRFs is at least
sensitive to the scanner model by the same manufacturer. Moreover, we anticipate based
on their definition that certain HRFs (such as histogram-based features) are less sensitive,
while others (e.g., texture features) are more sensitive to variations in scanning parameters
and/or imaging vendors. Generally, scans with more similar original IPRs, and those of
integer multiples of IPR showed higher numbers of concordant HRFs before and after
resampling. This can be explained by the mechanisms by which a scan is acquired. When
all other scanning parameters are fixed, the variations in IPR will result in variations in
the number of pixels in 2D, while the other dimensions are preserved. Therefore, when
all other parameters are fixed, the closer the IPR values are, the closer the values of the
extracted HRFs.
For the IMs, the number of HRFs that had better/worse concordance after resampling
was dependent on the NUIR chosen and scanner model. The window sinc interpolation
family performed consistently better on both scanners and NUIRs investigated. In the field
of radiology, both NN and linear are known to result in imprecisions [26,35]. A study into
the reproducibility of HRFs investigated the performance of B-spline, linear, and NN using
a single image slice thickness, and it concluded that NN is not a favorable method for
the reproducibility of HRFs [42]. Our results support these previous reports by showing
that NN and linear IMs are not the best candidates for improving the reproducibility of
HRFs among scans acquired with different IPRs, and their use led to lower numbers of
concordant HRFs in many of the investigated scenarios.
With regard to the selection of NUIR, a common trend of an inverse relationship
between the NUIR and the number of concordant HRFs following resampling was observed.
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This trend was observed in both scanner models investigated. However, the percentage
difference between the concordant HRFs is not significant at the lower end of the NUIR
spectrum (Figure 3, Figure 4, Figures S2, and S3; Tables S5 and S6). As the best NUIR
is expected to be task dependent (for e.g., classification of a lesion, predicting response
to therapy or overall survival, etc.), outcome-based analysis is needed to determine the
best NUIR. Yet, as a general rule, the smaller the NUIR, the better the concordance. In
addition, while the number of non-highly correlated HRFs was found to be low on both
scanner models (nine and 11 HRFs before and after ComBat harmonization, respectively),
the exclusion of highly correlated HRFs should be performed based on the effects of the
removal of these HRFs on the model performance.
A previous study investigated the effects on HRFs of voxel size resampling using
linear interpolation. The authors resampled the scans of a phantom to a single voxel size,
which was larger than the largest voxel size in the original scans, and it reported that
around 20% of the HRFs (n = 213) became concordant after resampling [22]. Another
study also investigated the effects of voxel size on HRFs of lung cancer patients [21]. The
authors resampled all the scans to a single common voxel size using linear interpolation,
and they reported that resampling does not eliminate all the variations in feature values
even when the only variation in scan acquisition and reconstruction parameters was the
voxel size, but it is favorable to no resampling. Another group investigated the effects
of variation in several acquisition and reconstruction parameters on a 13-layer phantom
using a different approach, and they reported that resampling the scans to isotropic voxels
increased the percentage of concordant HRFs from 59.5% to 89.3% [43]. In this study, we
found a similar conclusion: the number of previously non-concordant HRFs that became
concordant following resampling to the lowest resolution ranged between 1.1% and 22%
depending on the IM, and not all HRFs benefit from image resampling.
In contrast to previous studies, we investigated more IMs and harmonization tech-
niques, and we propose a guideline on how to carefully approach HRFs reproducibility
studies. Furthermore, we found that linear interpolation is not a good candidate for the
purpose of improving the reproducibility of HRFs when compared to other available IMs,
and the performance of an IM is dependent on the original IPR values and the chosen
NUIR as well as the imaging vendor.
When pairwise comparisons were considered, the performance of ComBat harmo-
nization was found to be inferior to that of well-performing IMs, regardless of the NUIR.
Moreover, the combination of ComBat and the well-performing IMs did not yield sig-
nificantly better results compared to solely using the IM. Furthermore, the performance
of ComBat varied depending on the batches used. Nevertheless, when the number of
concordant HRFs across all pairs was considered, ComBat harmonization was of added
value in almost all scenarios. Therefore, ComBat application on HRFs should follow a
reproducibility study (phantom or tissue studies) to assess the impact of ComBat on the
reproducibility of HRFs in those settings and use only the harmonizable HRFs for further
radiomics analyses [15], as described in the workflow (Figure 1). The application of Com-
Bat without assessing HRFs’ reproducibility as described may result in the inclusion of a
high percentage of unreproducible HRFs or even the loss of some of the HRFs that were
originally reproducible, rendering the analysis of these HRFs meaningless. This finding
regarding ComBat harmonization is not in line with previous reports, which reported that
ComBat successfully removes the batch effects for all HRFs [28,44]. This could be attributed
to the differences in the radiomics software and/or the evaluation metrics used. In contrast
to previous studies, and as the aim of harmonization is to improve reproducibility but
not necessarily the performance of generated radiomic models, we opted for the CCC.
The CCC provides an accurate description of the reproducibility of HRFs, which is not
reflected in neither the distribution of HRFs nor the performance of radiomics models [45].
If radiomic models are to be used clinically, it is expected to be applied to one patient per
time. Therefore, the importance has been given in this study to the individual feature
values and not their distributions. HRFs with different values and order rank can share
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similar distributions, in which case the feature cannot be considered reproducible. In
addition, different modeling techniques may yield significantly different results on the
same dataset. Hence, the difference in the performance of a radiomic signature before
and after harmonization does not necessarily inform about the performance of the harmo-
nization method. Our proposed framework addresses this issue and guides the selection
of reproducible and harmonizable HRFs before developing a radiomic signature, which
helps the translation and generalization of results, and ultimately the inclusion of radiomic
signatures in clinical practice.
Of note, not all HRFs benefit from resampling all scans to a NUIR or using ComBat
harmonization. Some HRFs lost their concordance following resampling, depending on
the IM employed and the chosen NUIR. The combination of IMs and NUIRs affected the
HRFs differently on different scanner models. Some HRFs were not found to be concordant
on one of the scanner models before or after resampling to any of the available NUIRs
using any of the IMs, but they were found to be concordant on the other scanner model.
Other HRFs were found to be concordant across different scanner models and IPRs. These
findings indicate the need for performing reproducibility studies depending on the data
under study, and the fact that at this level, we are unable to provide a list of HRFs that can
be used regardless of the acquisition and reconstruction parameters and scanner models
used. However, it lays down the basis for identifying reproducible HRFs before performing
data analysis. In real-life scenarios, the variations between the imaging parameters in
retrospective cohorts (especially multicentric) are usually not only limited to the IPR. Aside
from the scanner/scanning parameters combination variations, some of the effects will
be attributed to patient populations. Furthermore, while phantom studies reflect on the
reproducibility of HRFs extracted from anthropomorphic phantoms, HRFs extracted from
human tissue are expected to have a wider range of variations due to the inclusion of
biologic factors. This knowledge, combined with our findings, necessitate the critical inves-
tigation of the reproducibility of HRFs across the different scanning parameters/scanners
before performing any statistical analysis, and future investigations into the effects of
differences in acquisition and reconstruction parameters on the reproducibility of HRFs
extracted from human tissues, if feasible. Directly performing radiomics analysis on data
acquired heterogeneously leads to spurious results and lacks meaningful interpretation.
Henceforth, we reiterate the need for using our proposed robust radiomics analysis frame-
work for addressing differences in IPR. Furthermore, the workflow can be generalized to
evaluate other harmonization methods.
5. Conclusions
The reproducibility of a given HRF, and its harmonizabilty with ComBat are not
constants, but they depend on the degree of variation in a single reconstruction parameter
(the in-plane resolution) of the scans being analyzed. This implies that additional changes
in the acquisition and reconstruction parameters could further reduce the number of
reproducible and harmonizable HRFs. When scans acquired with different IPR values are
to be analyzed, resampling the scans to a unified resolution can significantly improve the
reproducibility of HRFs. Interpolation methods (CWS, HWS, BWS, WWS, and B-spline)
were found to be superior to ComBat harmonization alone in addressing the variations
in HRFs attributed to differences in IPR, and the combination of an IM with ComBat
following NUIR could increase the number of reproducible HRFs in some scenarios. The
application of our proposed framework aids the selection of data- and outcome-specific
interpolation and harmonization methods, and it is expected to improve the translation
and generalizability of radiomics analyses.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
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LightSpeed Pro 32 model, Figure S3: The percentage of concordant features following resampling and
ComBat harmonization compared to no resampling with linear trendlines, LightSpeed Pro 32 model,
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